Tamturbo experienced strong sales growth in 2019. The Company’s first air compressors were sold in 2017, and by the end of 2019, the Company had sold 18 units to eleven different customers globally. The Company estimates that its current customers have a total of more than 1,500 compressors from various manufacturers in use in hundreds of different factories, and the Company is in negotiations with tens of similar potential customers. In 2019, the Company’s net sales were approximately EUR 2.1 million, an increase of approximately 285 per cent compared to 2018. The Company is well positioned and needs additional capital due to new orders and for generally growing global demand, which is why the Company is arranging the IPO and intends to apply for its shares to be traded on First North.
The Company aims to raise approximately EUR 6.0 million in the IPO. The Company plans to use the net proceeds of the IPO for the following purposes:
- To increase the sales, marketing and customer service organisation in order to enhance the global “go-to-market” strategy.
- To create growth in inventories and financing capital tied up to accounts receivable.
- Expansion of other operations to meet growth targets.
- The necessary capital expenditures as the sales volume increases, the most significant of which is the planned expansion of the test laboratory.
The Board of Directors has decided on an Additional Share Allotment to be executed in the event of an oversubscription of the IPO. If the Additional Share Allotment is subscribed in full, the Company’s gross proceeds from the IPO will increase by approximately EUR 1.5 million.
Augment acts as the Company’s financial adviser in the IPO and as its Certified Adviser.